Leica Biosystems

A new PD-L1 BOND Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need

NEWCASTLE, England, Nov. 13, 2018 /PRNewswire/ — Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform. The new PD-L1 (programmed death – ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by UK-based Abcam on behalf of […]